Hoechst PakistanKAR:HPL +0.08%86 PB Ratio is 4.35 as of Jun. 26, 2026, which is 101% above its 10-year median of 2.16. GuruFocus rates KAR:HPL with a GF Score™ of 86/100 and a GF Value™ of ₨3,253.76 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 922 Drug Manufacturers companies, Hoechst Pakistan ranks worse than 79.61% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Hoechst Pakistan's share price is ₨4015.00. Hoechst Pakistan's Book Value per Share for the quarter that ended in Mar. 2026 was ₨923.19. Hence, Hoechst Pakistan's PB Ratio of today is 4.35.
Good Sign:
Hoechst Pakistan Ltd stock PB Ratio (=4.34) is close to 1-year low of 4.09.
The historical rank and industry rank for Hoechst Pakistan's PB Ratio or its related term are showing as below:
KAR:HPL'
s PB Ratio Range Over the Past 10 Years
Min: 1.04 Med: 2.16 Max: 9.16
Current: 4.35
During the past 13 years, Hoechst Pakistan's highest PB Ratio was 9.16. The lowest was 1.04. And the median was 2.16.
KAR:HPL's PB Ratio is ranked worse than 79.61% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs KAR:HPL: 4.35
During the past 12 months, Hoechst Pakistan's average Book Value Per Share Growth Rate was 20.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 17.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hoechst Pakistan was 21.30% per year. The lowest was 3.20% per year. And the median was 8.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hoechst Pakistan PB Ratio Related Terms
Hoechst Pakistan PB Ratio Historical Data
* Premium members only.
The historical data trend for Hoechst Pakistan's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Hoechst Pakistan's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoechst Pakistan PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hoechst Pakistan's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hoechst Pakistan (KAR:HPL) has a PB Ratio of 4.35 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hoechst Pakistan and its competitors. This is 101% above median its historical median of 2.16. Over the past decade, Hoechst Pakistan's PB Ratio has ranged from 1.04 to 9.16. According to the industry distribution chart, Hoechst Pakistan ranks #734 out of 922 companies in the Drug Manufacturers industry, placing it in the top 79.6%.
Is Hoechst Pakistan's PB Ratio too high?
Hoechst Pakistan's current PB Ratio of 4.35 is 101% above median its 10-year median of 2.16. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 9.16. The Drug Manufacturers industry median PB Ratio is 1.83. Hoechst Pakistan's value of 4.35 is 138.4% above this industry median. Based on the distribution chart, Hoechst Pakistan ranks #734 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hoechst Pakistan has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoechst Pakistan's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Hoechst Pakistan ranks #734 out of 922 companies for PB Ratio. This places Hoechst Pakistan in the lower half of its industry. The industry median PB Ratio is 1.83. Hoechst Pakistan's value of 4.35 is 138.4% above this benchmark. Historically, Hoechst Pakistan's own PB Ratio has ranged from 1.04 to 9.16 over the past decade. While the company's 10-year median is 2.16 vs. the industry median of 1.83, Hoechst Pakistan has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoechst Pakistan's current PB Ratio of 4.35 is 138.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hoechst Pakistan and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoechst Pakistan's current PB Ratio is 4.35, which is 101% above median its own 10-year median of 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoechst Pakistan stock overvalued right now?
Based on GuruFocus' analysis, Hoechst Pakistan (KAR:HPL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨3,253.76, compared to a current price of ₨4,015.00 — trading 23.4% above its estimated fair value. The current PB Ratio is 4.35, which is 101% above median its 10-year median of 2.16 and 138.4% above the Drug Manufacturers industry median of 1.83. Hoechst Pakistan's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hoechst Pakistan (KAR:HPL), the current PB Ratio is 4.35 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoechst Pakistan (KAR:HPL) Overvalued in 2026?
Based on GuruFocus' analysis, Hoechst Pakistan stock appears to be overvalued.
The current stock price of ₨4,015.00 is trading 23.4% above its estimated GF Value™ of ₨3,253.76.
GuruFocus considers Hoechst Pakistan to be Modestly Overvalued.
Key valuation signals for KAR:HPL:
PB Ratio: 4.35 (101% above median its 10-year median of 2.16)
GF Value™: ₨3,253.76 vs. price of ₨4,015.00 (23.4% above fair value)
Industry Position: 138.4% above the Drug Manufacturers median (#734 of 922)
No single metric tells the full story. See the KAR:HPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoechst Pakistan Ltd is a healthcare company of Pakistan, focused on patient needs and engaged in the manufacturing, promotion, and sale of pharmaceutical and vaccines. The company engages in the manufacturing, selling and trading of pharmaceutical and related products.
86GF Score
Get the complete analysis for KAR:HPL
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:HPL has been successfully added to your 
